Coronary atherosclerosis and cerebrovascular damage in a patient with systemi9c lupus erythematosus with antiphospholipid syndrome

QR Code

Coronary atherosclerosis and cerebrovascular damage in a patient with systemi9c lupus erythematosus with antiphospholipid syndrome

Saved in:

Bibliographic Details
Main Authors:	N V Seredavkina, T M Reshetnyak, D V Burenchev, L V Kondratyeva, E L Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2008-06-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/804
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Aminoquinoline drugs in the treatment of systemic lupus erythematosus and antiphospholipid syndrome
by: L V Kondratyeva, et al.
Published: (2008-08-01)

Atherosclerotic vessel damage in systemic lupus erythematosus and antiphospholipid syndrome in men
by: A. I. Iljina, et al.
Published: (2005-10-01)

Antiphospholipide antibodies subtypes in systemic lupus erythematosus and antiphospholipid syndrome
by: T M Reshetnyak, et al.
Published: (2005-10-01)

Netosis in the pathogenesis of antiphospholipid syndrome and systemic lupus erythematosus
by: K. S. Nurbaeva, et al.
Published: (2021-10-01)

OSTEOPOROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: N V Seredavkina, et al.
Published: (2009-12-01)

Aspergillosis in systemic lupus erythematosus
by: T. M. Reshetnyak, et al.
Published: (2016-05-01)

ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS: WHAT DISEASE IS A CAUSE OF ORGAN DAMAGES?
by: F. A. Cheldieva, et al.
Published: (2020-04-01)

ACTOVEGIN IN THE COMPLEX THERAPY OF VASCULAR DISORDERS IN ANTIPHOSPHOLIPID SYNDROME
by: N V Seredavkina, et al.
Published: (2010-06-01)

Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-11-01)

Extra criterial antiphospholipid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data)
by: F. A. Cheldieva, et al.
Published: (2021-10-01)

Efficacy and safety of long-term use of low molecular weight heparins in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2023-10-01)

The specific features of cerebrovascular disease in systemic lupus erythematosus
by: D L Faizulina, et al.
Published: (2012-06-01)

Von Willebrand factor antigen in systemic lupus erythematosus and antiphospholipid syndrome
by: A A Novikov, et al.
Published: (2004-08-01)

Antibodies to domain I β2 -glycoprotein 1 in patients with antiphospholipid syndrome and systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-07-01)

Efficacy and tolerance of selective and non-selective factor Xa inhibitors in the prevention of thrombosis in kidney disease in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2019-03-01)

Citrullinated histone H3 in systemic lupus erythematosus and antiphospholipid syndrome (preliminary results)
by: K. S. Nurbaeva, et al.
Published: (2023-08-01)

A family case of systemic lupus erythematosus with antiphospholipide syndrome
by: O L Alexandrova, et al.
Published: (2005-08-01)

Irreversible organ damages in a cohort of patients with systemic lupus erythematosus (RENAISSANCE)
by: E. A. Aseeva, et al.
Published: (2016-10-01)

Irreversible organ damages in patients with systemic lupus erythematosus. SLICC damage index
by: E. S. Solovyeva, et al.
Published: (2016-03-01)

A case of primary antiphospholipid syndrome under the mask of systemic lupus erythematosus
by: N. S. Pozhilenko, et al.
Published: (2022-03-01)

Pulmonary artery trunk thrombosis as a manifestation of antiphospholipid syndrome in systemic lupus erythematosus
by: T L Zlobina, et al.
Published: (2004-06-01)

Galectins, antibodies to them and galectin-3 binding protein in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2025-03-01)

ISCHEMIC STROKE IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND SECONDARY ANTIPHOSPHOLIPID SYNDROME
by: P. S. Nikitenko, et al.
Published: (2019-07-01)

Difficulties in management of patients with systemic lupus erythematosus and antiphospholipid syndrome in combination with melanoma and infiltrative tuberculosis (clinical observations)
by: A. A. Shumilova, et al.
Published: (2021-08-01)

Cardiovascular disturbances and atherosclerosis risk Гасtore in systemic lupus erythematosus
by: T V Popkova, et al.
Published: (2004-08-01)

THE IX EUROPEAN FORUM ON ANTIPHOSPHOLIPID ANTIBODIES. A BRIEF REVIEW
by: Nataliya V Seredavkina, et al.
Published: (2014-03-01)

Multiple sclerosis and rheumatic diseases: Rheumatoid arthritis, antiphospholipid syndrome, and systemic lupus erythematosus
by: M.A. Hernández, et al.
Published: (2025-07-01)

Hyperhomocysteinemia - an additional risk factor of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome
by: I. E. Shirokova, et al.
Published: (2003-08-01)

Clinical and endoscopic assessment of gastric state in systemic lupus erythematosus and antiphospholipid syndrome
by: I. A. Doroshkevich, et al.
Published: (2004-06-01)

BELIMUMAB: ADVANCES IN DRUG THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS
by: Evgeny Lvovich Nasonov, et al.
Published: (2012-10-01)

Systemic lupus erythematosus and pregnancy: Before gestation, during and after childbirth
by: T. M. Reshetnyak, et al.
Published: (2023-06-01)

Early damage index in systemic lupus erythematosus
by: I A Andrianova, et al.
Published: (2005-10-01)

PREVENTION OF THROMBOSES IN ANTIPHOSPHOLIPID SYNDROME
by: Lyubov Valeryevna Kondratyeva, et al.
Published: (2009-09-01)

Contraception for antiphospholipid syndrome and systemic lupus erythematosus (according to the recommendations of the European Alliance of Associations for Rheumatology/American College of Rheumatology, EULAR/ACR)
by: T. M. Reshetnyak, et al.
Published: (2024-03-01)

Systemic lupus erythematosus: history and modernity
by: E. L. Nasonov, et al.
Published: (2022-09-01)

ROLE OF INFLAMMATION MARKERS IN DEVELOPMENT OF ATHEROSCLEROSIS AND ITS COMPICATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Tatiyana Valentinovna Popkova, et al.
Published: (2014-02-01)

Clinical significance of leptin in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2021-12-01)

PROSPECTS FOR PHARMACOTHERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: E. L. Nasonov, et al.
Published: (2014-06-01)

Survival of men with systemic lupus erythematosus
by: N G Klyukvina, et al.
Published: (2009-12-01)

HEADACHE, SEIZURES, COGNITIVE DISORDERS, AND CEREBROVASCULAR DISEASES AS THE MOST COMMON NEUROPSYCHIC SYNDROMES IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: N. V. Pizova
Published: (2014-06-01)